J Mol Diagn. 2018 Jun 21. pii: S1525-1578(17)30491-9. [Epub ahead of print]
Mitochondrial DNA copies per cell (mtDNA content) can fluctuate with cellular aging, oxidative stress, and mitochondrial dysfunction, and has been investigated in cancer, diabetes, Human immunodeficiency virus, and metabolic disease. mtDNA content testing in both clinical and basic settings is expected to rise as research uncovers its biological relevance. Here, we present a novel mtDNA content assay developed on monochrome, multiplex qPCR (MMqPCR) principles. This assay offers a >2-fold improvement on time- and cost-effectiveness over conventional (monoplex) qPCR, as well as improved reproducibility given the reduced effects of human pipetting errors. The new MMqPCR method was compared with the gold standard monoplex qPCR assay on DNA from a variety of sources, including human whole blood, skeletal muscle, and commercial cell lines. The MMqPCR assay is reproducible (n=98, r=0.99, P < 0.0001) and highly correlated to the monoplex qPCR assay (n=160, r>0.98, P < 0.0001). Intra- and inter-assay variabilities, as established independently by multiple operators, range between 4.3% to 7.9% and 2.9% to 9.2%, respectively. This robust assay can quantify >82 pg of template DNA per reaction, with a minimum mtDNA:nuclear DNA ratio of 20, and is especially suitable for studies that require high throughput.